Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Peng-Peng Xu · SciRah

Researcher profile · Semantic Scholar

Peng-Peng Xu

Share profile

Peng-Peng Xu — researcher profile on SciRah

h-index: 25
Works: 163
Citations: 2,360

Most-cited papers

Butyrate-producing Eubacterium rectale suppresses lymphomagenesis by alleviating the TNF-induced TLR4/MyD88/NF-κB axis.
Haiyang Lu, Xiao-Qiang Xu, D. Fu, Yu-Bei Gu +13 more
2022Cell Host and Microbe168 citations Open access
Semantic Scholar
Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial.
Mu-Chen Zhang, Shuang Tian, D. Fu, Li Wang +15 more
2023Cancer Cell113 citations Open access
Semantic Scholar
Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma
R. Shen, D. Fu, Lei Dong, Mu-Chen Zhang +6 more
2023Signal Transduction and Targeted Therapy102 citations Open access
Semantic Scholar
Transgenic expression of IL-7 regulates CAR-T cell metabolism and enhances in vivo persistence against tumor cells
Li Li, Qing Li, Zi-Xun Yan, Ling-Shuang Sheng +4 more
2022Scientific Reports66 citations Open access
Semantic Scholar
SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential
J. Xiong, Nan Wang, H. Zhong, Bowen Cui +9 more
2021EBioMedicine50 citations Open access
Semantic Scholar
Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma
Zi-Xun Yan, Yan Dong, Niu Qiao, Yilun Zhang +8 more
2024Nature Communications46 citations Open access
Semantic Scholar
Outcomes in refractory diffuse large B‐cell lymphoma: results from a multicenter real‐world study in China
Shuo Wang, Li Wang, Jian-Da Hu, Wen-Bin Qian +16 more
2021Cancer Communications41 citations Open access
Semantic Scholar
Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma
Ying Fang, Mu-Chen Zhang, Yang He, Chen Li +8 more
2023Signal Transduction and Targeted Therapy39 citations Open access
Semantic Scholar
Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cells
Rui Sun, Peipei Zhang, Xiang-Qin Weng, Xiao-Dong Gao +13 more
2022Signal Transduction and Targeted Therapy37 citations Open access
Semantic Scholar
Genomic and transcriptomic profiling of peripheral T cell lymphoma reveals distinct molecular and microenvironment subtypes
Yao-Hui Huang, Yu-Ran Qiu, Qun-Ling Zhang, M. Cai +8 more
2024Cell Reports Medicine31 citations Open access
Semantic Scholar
Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study.
Peng-Peng Xu, Zi-Yang Shi, Ying Qian, Shu Cheng +9 more
2022The Lancet Healthy Longevity26 citations Open access
Semantic Scholar
All roads lead to targeted diffuse large B-cell lymphoma approaches.
Peng-Peng Xu, Yu-Jia Huo, Wei-Li Zhao
2022Cancer Cell24 citations Open access
Semantic Scholar
Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma
Yue Wang, Q. Shi, Zi-Yang Shi, Shuang Tian +11 more
2024Blood Advances23 citations Open access
Semantic Scholar
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma
J. Xiong, Shu Cheng, Xiao Gao, Shan-He Yu +13 more
2024Signal Transduction and Targeted Therapy23 citations Open access
Semantic Scholar
GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis.
Jie Xiong, Yu-Ting Dai, Wen-Fang Wang, Hao Zhang +17 more
2023Science Bulletin23 citations Open access
Semantic Scholar
Extranodal diffuse large B‐cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study
Si-Yuan Chen, Peng-Peng Xu, R. Feng, G. Cui +43 more
2025Cancer Communications22 citations Open access
Semantic Scholar
Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma
Yue Zhu, D. Fu, Q. Shi, Zi-Yang Shi +11 more
2022Frontiers in Immunology22 citations Open access
Semantic Scholar
A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes
Ping Zhao, Meng-Meng Ji, Ying Fang, Xiao Li +8 more
2021Cell Death and Disease20 citations Open access
Semantic Scholar
Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy
Zi-Xun Yan, Li Li, D. Fu, Wen Wu +12 more
2023Frontiers in Medicine18 citations
Semantic Scholar
KMT2D mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC/TGF-β1 axis
Qing-Xiao Liu, Yue Zhu, H. Yi, Yi-Ge Shen +11 more
2024International Journal on Biological Sciences17 citations Open access
Semantic Scholar
CD47 overexpression is related to tumour‐associated macrophage infiltration and diffuse large B‐cell lymphoma progression
Yi-Ge Shen, Meng-Meng Ji, H. Yi, R. Shen +7 more
2024Clinical and Translational Medicine15 citations Open access
Semantic Scholar
Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III study
H. Zhong, Shu Cheng, Xi Zhang, Bin Xu +47 more
2023Innovation (Cambridge (Mass.))15 citations Open access
Semantic Scholar
The genetic landscape of histologically transformed marginal zone lymphomas
An-Qi Li, H. Yi, Shijie Deng, Miao Ruan +17 more
2023Cancer15 citations
Semantic Scholar
Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
Yu-Jia Huo, Peng-Peng Xu, D. Fu, H. Yi +10 more
2022Blood Cancer Journal15 citations Open access
Semantic Scholar
Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical trial
M. Cai, Shu Cheng, H. Jing, Yan Liu +9 more
2024The Lancet Regional Health - Western Pacific13 citations Open access
Semantic Scholar
The Prognostic Significance of CD79B Mutation in Diffuse Large B-Cell Lymphoma: A Meta-analysis and Systematic Literature Review.
Peng-Peng Xu, R. Shen, Zi-Yang Shi, Shu Cheng +9 more
2022Clinical Lymphoma, Myeloma & Leukemia13 citations
Semantic Scholar
A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma
Peng-Peng Xu, Yue Zhu, Zi-Yang Shi, Li Wang +11 more
2025Blood12 citations
Semantic Scholar
Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphoma
Mengke Liu, L. Cheng, H. Yi, Yang He +11 more
2022Frontiers in Oncology12 citations Open access
Semantic Scholar
Dynamic change in Epstein-Barr virus DNA predicts prognosis in early stage natural killer/T-cell lymphoma with pegaspargase-based treatment: long-term follow-up and biomarker analysis from the NHL-004 multicenter randomized study
H. Zhong, Shu Cheng, J. Xiong, Jia-Yi Chen +48 more
2025Haematologica11 citations Open access
Semantic Scholar
Genetic subtype-guided immunochemotherapy in relapsed and refractory diffuse large B cell lymphoma: a phase 2 investigator-initiated nonrandomized clinical trial (GUIDANCE-06)
Yi-Ge Shen, Q. Shi, Wei Tang, Peng-Peng Xu +6 more
2025Signal Transduction and Targeted Therapy11 citations Open access
Semantic Scholar
Development and validation of prognostic scoring in primary intestinal diffuse large B-cell lymphoma: a single-institution study of 184 patients
Xing Fan, L. Zang, Bing-bing Zhao, H. Yi +7 more
2021Annals of Translational Medicine11 citations Open access
Semantic Scholar
Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology
Yu-Qing Wang, Shuo Wang, H. Yi, Ying Qian +14 more
2025Cell Reports Medicine10 citations Open access
Semantic Scholar
Tucidinostat plus R-CHOP in previously untreated diffuse large B-cell lymphoma with double expression of MYC and BCL2: An interim analysis from the phase III DEB study.
Wei-Li Zhao, Jun Zhu, Yu-Qin Song, Peng-Peng Xu +16 more
2024Journal of Clinical Oncology10 citations Open access
Semantic Scholar
Positron emission tomography‐adapted therapy in low‐risk diffuse large B‐cell lymphoma: results of a randomized, phase III, non‐inferiority trial
Q. Shi, Yang He, H. Yi, Rong-Ji Mu +10 more
2023Cancer Communications10 citations Open access
Semantic Scholar
Practical Microenvironment Classification in Diffuse Large B-Cell Lymphoma Using Digital Pathology
Yu-Qing Wang, Shuo Wang, Hong-Mei Yi, Yue Wang +10 more
2024Blood9 citations
Semantic Scholar
Integrated Genomic and Transcriptomic Analyses of Diffuse Large B-Cell Lymphoma With Multiple Abnormal Immunologic Markers
L. Sheng, D. Fu, Yi-Wen Cao, Yu-Jia Huo +6 more
2022Frontiers in Oncology9 citations Open access
Semantic Scholar
Dual targeting PD-L1 and 4-1BB to overcome dendritic cell-mediated lenalidomide resistance in follicular lymphoma
Zhong Zheng, Jian-biao Wang, Rui Sun, Nan Wang +11 more
2025Signal Transduction and Targeted Therapy7 citations Open access
Semantic Scholar
18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in patients with high tumor burden
Ling-Shuang Sheng, R. Shen, Zi-Xun Yan, Chao Wang +12 more
2024Biomarker Research7 citations
Semantic Scholar
Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients Managed at Chinese Academic Centers in the Rituximab Era: A Real-World Study
Meng Wu, Yun Li, Hui-Qiang Huang, Wei Xu +10 more
2022Frontiers in Oncology6 citations Open access
Semantic Scholar
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma
Yu-Jia Huo, Peng-Peng Xu, Li Wang, H. Zhong +6 more
2022Biomarker Research6 citations Open access
Semantic Scholar
Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical Trial.
Peng-Peng Xu, Yu-Qin Song, Jian Shen, Qing-Qing Cai +41 more
2026Journal of the American Medical Association (JAMA)5 citations Open access
Semantic Scholar
Response‐adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T‐cell therapy in relapsed/refractory large B‐cell lymphoma: A retrospective observational study
R. Shen, W. Cao, Li Wang, Ling-Shuang Sheng +15 more
2025Clinical and Translational Medicine5 citations Open access
Semantic Scholar
Integrative genome‐wide chromatin accessibility and transcriptome profiling of diffuse large B‐cell lymphoma
Ying Fang, Mu-Chen Zhang, Peng-Peng Xu, Su-jiang Zhang +11 more
2022Clinical and Translational Medicine5 citations Open access
Semantic Scholar
A prognostic index integrating deep learning baseline PET/CT biomarkers and multi-omics profiling in diffuse large B cell lymphoma
Yue Wang, Xue Wang, Xin-Yun Huang, H. Jing +16 more
2025Cell Reports Medicine4 citations
Semantic Scholar
Molecular heterogeneity of CD30+ peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre study
Yu-Jia Huo, Shu Cheng, H. Yi, Ting Niu +20 more
2025EBioMedicine4 citations Open access
Semantic Scholar
A phase 1 study of LY007, a novel anti-CD20 CAR-T cell therapy in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
Zixun Yan, Ling-Shuang Sheng, Li Wang, Wen Wu +13 more
2024Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Primary extranodal diffuse large B‐cell lymphoma: Molecular features, treatment, and prognosis
Si-Yuan Chen, Meng-Meng Ji, Peng-Peng Xu, Wei-Li Zhao
2022Aging and Cancer4 citations Open access
Semantic Scholar
CSNK1E Sustains Stem-like Drug Persistence in Diffuse Large B-cell Lymphoma.
Xiang Li, Mengke Liu, Q. Shi, Zhijun Du +14 more
2026Blood3 citations
Semantic Scholar
Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor
Zi-Yang Shi, Ying Fang, Peng-Peng Xu, H. Yi +14 more
2024Clinical and Translational Medicine3 citations Open access
Semantic Scholar
The clinical characteristics of anemia in native adults living at different altitudes of the Tibetan Plateau
Jie Fang, Ran Li, Dong-Dong Ye, Liang Chen +14 more
2023Scientific Reports3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Wei-Li Zhao×47
Invite
Wei-Li Zhao — researcher profile on SciRah
Shu Cheng×37
Invite
Shu Cheng — researcher profile on SciRah
D. Fu×22
Invite
D. Fu — researcher profile on SciRah
Li Wang×20
Invite
Li Wang — researcher profile on SciRah

×13

Invite

H. Yi — researcher profile on SciRah

Invite

H. Yi — researcher profile on SciRah

Invite

Li Wang — researcher profile on SciRah

Invite

Q. Shi — researcher profile on SciRah

Invite

R. Shen — researcher profile on SciRah

Xu-Feng Jiang×8

Invite

Xu-Feng Jiang — researcher profile on SciRah

Invite

Rong-Ji Mu — researcher profile on SciRah

Bin-Shen Ou-Yang×7

Invite

Bin-Shen Ou-Yang — researcher profile on SciRah